In addition to comparing existing therapies, the researchers will use their model to develop treatment plans that
adapt as the tumor changes.
Not exact matches
The HER2 pathway is mutated in many cancers, which drives
tumors, but inhibitors of this pathway, such
as lapatinib, have only limited success because cancer cells quickly
adapt.
«
As we continue to advance our knowledge of
tumor biology, we have learned that cancer cells have a remarkable ability to
adapt and become resistant to targeted therapies.